Related Experiment Video

Updated: May 21, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Racial differences in fibrosis progression after HCV-related liver transplantation

Jennifer E Layden1, Scott Cotler, Kimberly A Brown

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA. Jlayde1@uic.edu

Transplantation
|June 30, 2012
PubMed

Insights

Black recipients of liver transplants (LT) from white donors experience faster hepatitis C virus (HCV) related fibrosis progression and decreased survival. Further research is needed to understand these disparities in liver transplant outcomes.

Area of Science:

  • Hepatology
  • Transplantation immunology
  • Organ transplantation

Background:

  • Black recipients of liver transplants (LT) for hepatitis C virus (HCV) show poorer outcomes than white recipients.
  • Discrepancies are mainly observed in black recipients receiving livers from white donors.
  • The underlying causes for these differences, potentially linked to HCV recurrence and fibrosis, remain unclear.

Purpose of the Study:

  • To investigate and compare liver fibrosis progression in black and white liver transplant recipients with hepatitis C virus (HCV).
  • To assess the impact of donor race on fibrosis progression and patient survival after HCV-related LT.
  • To identify potential disparities in outcomes based on recipient-donor race combinations.

Main Methods:

  • A multisite cohort study comparing fibrosis progression in 105 black and 364 white recipients post-HCV LT.
  • Analysis of liver fibrosis stages (F3/F4) at 6, 12, and 24 months after transplantation.
  • Assessment of patient survival rates across different recipient-donor race combinations.

Main Results:

  • The black recipient/white donor (B/W) group exhibited significantly higher rates of severe fibrosis (F3/F4) compared to other race combinations.
  • The adjusted odds ratio for severe fibrosis in the B/W group was 2.54, indicating a substantially increased risk.
  • Black recipients with black donors showed fibrosis progression rates similar to white recipients, and patient survival was lower in the B/W group.

Conclusions:

  • African American recipients receiving livers from white donors experience accelerated fibrosis progression following HCV-related LT.
  • This high-risk, race-mismatched group warrants further investigation into the mechanisms driving accelerated fibrosis.
  • Understanding these mechanisms is crucial for improving long-term outcomes in liver transplantation.
Abstract

More Related Videos

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

Picrosirius Red Staining for Semiquantitative Histopathologic Evaluation of Collagen Deposition in Murine Models of Chronic Lung Allograft Rejection04:42

Picrosirius Red Staining for Semiquantitative Histopathologic Evaluation of Collagen Deposition in Murine Models of Chronic Lung Allograft Rejection

Published on: March 21, 2025

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...